Basic Info.
Production Capacity
20kg/Month
Certificate of Analysis
Product Name: Rimegepant sulfate
CAS:1374024-48-2
| Batch No. |
HF160822 |
Quantity |
1240kgs |
| Mfg. Date |
Aug. 22, 2016 |
Package |
As required |
| Rep. Date |
Aug. 25, 2016 |
Exp. Date |
Aug. 21, 2018 |
| Items |
Standards |
Results |
| Appearance |
White or off-white powder |
Off-white powder |
| Identification |
By HPLC |
Complies |
| Melting Point |
120ºC~130ºC |
126ºC |
| Loss on Drying |
≤1.00% |
0.21% |
| Heavy Metals |
≤ 10ppm |
Complies |
| Sulfated Ash |
≤ 0.10% |
0.03% |
| Content |
17.5%~19.5% |
19.3% |
| Content |
≤ 0.1ppm |
0.09ppm |
| Lead VContent |
≤ 3.0ppm |
0.50ppm |
| Content |
≤ 0.1ppm |
0.10ppm |
| Content |
≤ 0.1ppm |
0.10ppm |
| Microbiological Test |
Coliforms:Negative |
Negative |
| Salmonella: Negative |
Complies |
| Total plate count: ≤1000 CFU/g |
Pass |
| Yeast&Mold: ≤50 CFU/g |
Pass |
| Related Substances |
Impurity A: ≤0.30% |
0.18% |
| Other unknown impurity: ≤0.10% |
0.07% |
| Total Impurities: ≤0.50% |
0.42% |
| Assay |
≥ 98.0% |
99.50% |
| Reference Standard |
USP Standard |
| Conclusion |
The product complied to USP standard. |
| Storage |
Preserve in tight,light-resistant containers in a cool place |
Rimegepant is a calcitonin gene-related peptide receptor antagonist for the acute treatment of migraine in adults with or without aura; Preventive treatment of adult episodic migraine. So what is the effect of remizepam? How long does medication take?
The effect of Remizepam
Rimegepant blocks the action of CGRP in the central nervous system, but CGRP is also active in blood vessels and the heart, leading to the possibility that blocking its vasodilator effect could put the organ at risk for ischemia.
Audited Supplier 
){kind=link}
){kind=link}